GxP Software

GxP software is any computerised system used in a Good Practice regulated environment — pharmaceutical manufacturing, clinical trials, laboratory operations, or distribution. These systems must be validated and maintain data integrity under regulations like 21 CFR Part 11, EU Annex 11, and GAMP 5. Examples include eQMS, LIMS, MES, ERP, validation management platforms, and document management systems.

The G stands for Good and the P for Practice; the x is a placeholder for the discipline being regulated. GMP is Good Manufacturing Practice, GCP is Good Clinical Practice, GLP is Good Laboratory Practice, GDP is Good Distribution Practice, and GVP is Good Pharmacovigilance Practice. The term exists so you can refer to the whole family without listing every member.

A GxP system is any computerised system that creates, modifies, maintains, archives, retrieves or transmits data supporting a regulated activity — or that otherwise influences a regulated decision. The test is dependency rather than category: if a GxP decision or record depends on the system, it is in scope and must be proven fit for its intended use. A tool that arranges information recorded properly elsewhere is generally not, which is why scoping by dependency rather than by software type is the step that keeps validation proportionate.

GCP is not an alternative to GxP — it is one of the GxPs. GxP is the umbrella term covering Good Manufacturing, Clinical, Laboratory, Distribution and Pharmacovigilance Practice; Good Clinical Practice is the member of that family governing trials conducted in people. Asking whether a system is GxP-compliant or GCP-compliant is a category error. The useful question is which of the Good Practices apply to what you are using the system for, and a single system can fall under several at once.

A typical pharmaceutical estate runs: an eQMS for deviations, CAPA, change control and training; a LIMS and often an ELN for laboratory work; an MES with electronic batch records on the production floor; a SCADA or DCS layer controlling equipment; a CTMS and EDC for clinical studies; a RIM system for registrations, submissions and labelling; a safety database for pharmacovigilance; an ERP such as SAP for materials and batch genealogy; and a validation management platform covering the lifecycle of all of them. Only the GxP-relevant portions of each are in scope, which matters most for ERP, where scoping by module rather than by regulatory impact is what makes validation unmanageable.

No. No regulator certifies software products as GxP-compliant, and any vendor claiming certification is describing something that does not exist. A supplier can be assessed, and their documented evidence can legitimately reduce your testing under a risk-based approach — but the validated state belongs to your implementation of their software, in your process, for your intended use. A vendor can make compliance easier or harder; they cannot transfer the obligation.

The main categories are: eQMS (quality management), LIMS (laboratory information), MES (manufacturing execution), ERP (enterprise resource planning), validation management (CSV/CSA lifecycle), document management (controlled documents and SOPs), clinical platforms (CTMS, eTMF, EDC), and AI-native platforms like GxP Copilot that use artificial intelligence to automate regulated workflows.

Start with your regulatory requirements and process needs. Evaluate vendors on compliance features (audit trail, Part 11, Annex 11), validation burden (how long to implement and validate), total cost of ownership, scalability, and vendor qualification. For mid-market companies, avoid enterprise platforms that require 6-month implementations and dedicated admin teams.

Yes. Any software supporting GxP-regulated processes must be validated before production use. Under GAMP 5 and Computer Software Assurance (CSA), validation effort is scaled to risk — high-impact GxP systems get rigorous testing, while low-risk configurations may rely on vendor qualification and documented verification.

It depends on category. For validation management, GxP Copilot leads with AI-native drafting. For eQMS, Veeva Vault Quality and MasterControl serve large enterprises while Qualio targets mid-market. For LIMS, LabWare and Benchling lead. For MES, Rockwell PharmaSuite and Siemens Opcenter. No single platform covers every GxP need.

We do not publish price ranges, because licensing in this category varies so widely with module scope, user count and organisation size that any figure would mislead more than it informs. What is more useful is knowing what drives total cost, because the licence is rarely the largest part. Three things dominate: how much of your requirement is configuration rather than development, because development is GAMP category 5 and carries category 5 validation depth; how much supplier evidence you can actually obtain and rely on, which directly reduces your own testing; and implementation effort, which frequently exceeds first-year licensing once validation, configuration, data migration and training are counted. Ask about all three during selection, while you still have leverage.

Excel can work for very small validation portfolios, but it lacks audit trails, electronic signatures, change control, and concurrent access. As your portfolio grows beyond 5-10 systems, spreadsheet-based validation becomes difficult to defend during inspections and increasingly expensive to maintain.